A hallmark of balancing selection is present at the promoter region of interleukin 10

Genes and Immunity

Volumn 7, Issue 8, 2006, Pages 680-683

  Wilson, J N ^a,b   Rockett, K ^a   Keating, B ^a   Jallow, M ^c   Pinder, M ^c   Sisay Joof, F ^c   Newport, M ^c   Kwiatkowski, D ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INTERLEUKIN 10; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 24; MK2 PROTEIN; UNCLASSIFIED DRUG;

AFRICA; ARTICLE; CONTROLLED STUDY; EUROPE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC PROCEDURES; GENETIC SELECTION; GENETIC VARIABILITY; HUMAN; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL SIGNIFICANCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FRANCE; GAMBIA; GENE COMPONENTS; HUMANS; INTERLEUKIN-10; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

EID: 33846977056     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364336     Document Type: Article

References (27)

1. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
2. Redpath S, Ghazal P, Gascoigne NRJ. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 2001; 9: 86-92.
3. Wall EM, Cao JX, Upton C. Subversion of cytokine networks by viruses. Int Rev Immunol 1998; 17: 121-155.
4. Lalani AS, McFadden G. Evasion and exploitation of chemokines by viruses. Cytokine Growth Factor Rev 1999; 10: 219-233.
5. Hsu DH, de Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, de Vries J et al. Expression of IL-10 activity by Epstein-Barr virus protein BCRF1. Science 1990; 250: 830-832.
6. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human cytomegalovirus harbours its own unique IL-10 homologue (cmvIL-10). Proc Natl Acad Sci USA 2000; 97: 1695-1700.
7. Redpath S, Angulo A, Gascoigne NR, Ghazal P. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL10. J Immunol 1999; 162: 6701-6707.
8. Fowler EV, Eri R, Hume G, Johnstone S, Pandeya N, Lincoln D et al. TNF and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J Med Genet 2005; 42: 523-528.
9. Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ et al. Relation of an interluekin-10 promoter polymorphism to graftversus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201-2210.
10. Eskdale J, McNicholl J, Wordsworth P, Jonas B, Huizinga T, Field M et al. Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 1998; 352: 1282-1283.
11. Wu MY, Chen HF, Chen SU, Chao KH, Yang YS, Ho HN. Increase in the production of interleukin-10 early after implantation is related to the success of pregnancy. Am J Reprod Immunol 2001; 46: 386-392.
12. Ozornek MH, Bielfeld P, Krussel JS, Moustafa M, Mikat-Drozdzynski B, Koldovsky U et al. Interferon gamma and interleukin 10 levels in preimplantation embryo culture media. J Assist Reprod Genet 1995; 12: 590-593.
13. Westendorp RG, van Dunne FM, Kirkwood TB, Helmerhorst FM, Huizinga TW. Optimizing human fertility and survival. Nat Med 2001; 7: 873.
14. Watier H, Auriault C, Capron A. Does Epstein-Barr virus infection confer selective advantage to malaria-infected children? Lancet 1993; 341: 612-613.
15. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989; 123: 585-595.
16. Hudson RR, Slatkin M, Maddison WP. Estimation of levels of gene flow from DNA sequence data. Genetics 1992; 132: 583-589.
17. Bamshad M,Wooding SP. Signatures of natural selection in the human genome. Nat Rev Genet 2003; 4: 99-111.
18. Hartl DL, Clark AG. Principles of Population Genetics. 3rd edn. Sinauer Associates Inc.: Sunderland, MA, USA, 1997.
19. Tishkoff SA, Williams SM. Genetic analysis of African populations: Human evolution and complex disease. Nat Rev Genet 2002; 3: 611-621.
20. Bamshad M, Mummidi S, Gonzalez E, Ahuja SS, Dunn DM, Watkins WS et al. A strong signature of balancing selection in the 5′ cis-regulatory region of CCR5. Proc Natl Acad Sci USA 2002; 99: 10539-10544.
21. Simonsen KL, Churchill GA, Aquadro CF. Properties of statistical tests of neutrality for DNA polymorphism data. Genetics 1995; 141: 413-429.
22. Harpending H, Rogers A. Genetic perspectives on human origins and differentiation. Ann Rev Genomics Hum Gen 2000; 1: 361-385.
23. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95: 9465-9470.
24. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101-1108.
25. Stone JR, Wray GA. Rapid evolution of cis-regulatory sequences via local point mutations. Mol Biol Evol 2001; 18: 1764-1770.
26. Dawson E, Abecasis GR, Bumpstead S, Chen Y, Hunt S, Beare DM et al. A first-generation linkage disequilibrium map of human chromosome 22. Nature 2002; 418: 544-548.
27. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.